ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | Enzymes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP5B | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A | Enzymes Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
ATP7A | ATPase, Cu++ transporting, alpha polypeptide | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
ATP8A1 | ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP9A | ATPase, class II, type 9A | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ATR | ATR serine/threonine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
AURKB | Aurora kinase B | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
B4GALT3 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
BACE1 | Beta-site APP-cleaving enzyme 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BAP1 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
BAZ1B | Bromodomain adjacent to zinc finger domain, 1B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
BCKDK | Branched chain ketoacid dehydrogenase kinase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
BDH1 | 3-hydroxybutyrate dehydrogenase, type 1 | Candidate cardiovascular disease genes Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
BDH2 | 3-hydroxybutyrate dehydrogenase, type 2 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
BHMT | Betaine--homocysteine S-methyltransferase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
BLM | Bloom syndrome, RecQ helicase-like | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Mixed |
BLMH | Bleomycin hydrolase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
BMP2K | BMP2 inducible kinase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
BPGM | 2,3-bisphosphoglycerate mutase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BRSK1 | BR serine/threonine kinase 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BUB1 | BUB1 mitotic checkpoint serine/threonine kinase | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
BUB1B | BUB1 mitotic checkpoint serine/threonine kinase B | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CA5B | Carbonic anhydrase VB, mitochondrial | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Mixed |
CA9 | Carbonic anhydrase IX | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CAD | Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CAMK4 | Calcium/calmodulin-dependent protein kinase IV | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CAMKK1 | Calcium/calmodulin-dependent protein kinase kinase 1, alpha | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CAMKK2 | Calcium/calmodulin-dependent protein kinase kinase 2, beta | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
CAMKMT | Calmodulin-lysine N-methyltransferase | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
CAPN1 | Calpain 1, (mu/I) large subunit | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CAPN2 | Calpain 2, (m/II) large subunit | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CARM1 | Coactivator-associated arginine methyltransferase 1 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CASP1 | Caspase 1, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
CASP3 | Caspase 3, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CASP6 | Caspase 6, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Mixed |
CASP8 | Caspase 8, apoptosis-related cysteine peptidase | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CAT | Catalase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CBR1 | Carbonyl reductase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CBR3 | Carbonyl reductase 3 | Enzymes Predicted intracellular proteins
| | | | | Mixed |
CCBL1 | Cysteine conjugate-beta lyase, cytoplasmic | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
CCRN4L | CCR4 carbon catabolite repression 4-like (S. cerevisiae) | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |